SCHEMBL4594987

SCHEMBL4594987

COc1ccc(Nc2ccc(OC)c3ccccc23)cc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 7/20 0.71
CTSV O60911 3/20 0.53
CTSL P07711 3/20 0.53
FABP4 P15090 1/20 0.52
KDM4E B2RXH2 1/20 0.51
APAF1 O14727 1/20 0.51
RECQL P46063 1/20 0.51
CASP6 P55212 1/20 0.51
CACNA1B Q00975 1/20 0.51
APBA1 Q02410 1/20 0.51
MCL1 Q07820 1/20 0.51
CASP8 Q14790 1/20 0.51
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
ANO1 Q5XXA6 1/20 0.50
ANO2 Q9NQ90 1/20 0.50
AKR1C3 P42330 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14030692 0.89 CDC25B (0.63) CDC25BCTSVCTSLFABP4RECQL
SCHEMBL4593706 0.83 CDC25B (0.74) CDC25BFABP4MEN1KMT2AAKR1C3
SCHEMBL4783198 0.83 CDC25B (1.00) CDC25BFABP4KDM4EAPAF1RECQL
SCHEMBL26106266 0.83 MEN1 (0.57) CDC25BCTSVCTSLKDM4EAPAF1
SCHEMBL27994523 0.79 PARP14 (0.49) CDC25BCTSVCTSLFABP4KDM4E
SCHEMBL4594920 0.79 CDC25B (0.67) CDC25BKDM4ERECQLMEN1KMT2A
SCHEMBL14048633 0.78 CDC25B (0.59) CDC25BCTSVCTSLFABP4MEN1
SCHEMBL4594364 0.78 CDC25B (0.62) CDC25BFABP4KDM4EMEN1KMT2A
SCHEMBL16737099 0.76 ANO1 (0.71) CDC25BCTSVCTSLRECQLMEN1
SCHEMBL4594836 0.76 CDC25B (0.69) CDC25BKDM4EMCL1MAPTAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US claimed
EP-1937243-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2008-07-02 EP claimed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO claimed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed
WO-2007045593-A2 NAPHTHYL DERIVATIVES AS INHIBITORS OF BETA-AMYLOID AGGREGATION SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation APP, BACE1, SNCA CDC25B 2914/4885CTSV 1126/4885CTSL 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.